Advanced small cell lung cancer (SCLC): new challenges and new expectations

Small cell lung cancer (SCLC) remains one of the most lethal malignancies and a major health riddle. The therapeutic options are limited. The combination of etoposide or irinotecan with platinum chemotherapy is the standard of care at any stage. The last decade systemic efforts have been done to rev...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Ann Transl Med
Главные авторы: Tsoukalas, Nikolaos, Aravantinou-Fatorou, Eleni, Baxevanos, Panagiotis, Tolia, Maria, Tsapakidis, Konstantinos, Galanopoulos, Michail, Liontos, Michail, Kyrgias, George
Формат: Artigo
Язык:Inglês
Опубликовано: AME Publishing Company 2018
Предметы:
Review Article on Breakthroughs in the Treatment of Advanced Lung Cancer: Making Progress Through Innovation
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5952028/
https://ncbi.nlm.nih.gov/pubmed/29862234
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2018.03.31
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы